CEPHALOSPORIN-RESISTANT NEISSERIA GONORRHOEAE - cdc 2025

Get Form
CEPHALOSPORIN-RESISTANT NEISSERIA GONORRHOEAE - cdc Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

How to edit CEPHALOSPORIN-RESISTANT NEISSERIA GONORRHOEAE - cdc in PDF format online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

Handling documents with our extensive and user-friendly PDF editor is easy. Follow the instructions below to fill out CEPHALOSPORIN-RESISTANT NEISSERIA GONORRHOEAE - cdc online easily and quickly:

  1. Log in to your account. Sign up with your email and password or register a free account to test the service before upgrading the subscription.
  2. Import a form. Drag and drop the file from your device or import it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
  3. Edit CEPHALOSPORIN-RESISTANT NEISSERIA GONORRHOEAE - cdc. Quickly add and underline text, insert pictures, checkmarks, and icons, drop new fillable fields, and rearrange or delete pages from your paperwork.
  4. Get the CEPHALOSPORIN-RESISTANT NEISSERIA GONORRHOEAE - cdc completed. Download your updated document, export it to the cloud, print it from the editor, or share it with other people via a Shareable link or as an email attachment.

Take advantage of DocHub, the most straightforward editor to promptly handle your paperwork online!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
CONCLUSION. Increase in N. gonorrhoeae isolates which are resistant to multiple antimicrobial agents including oral cephalosporins and the emergence of intermediate-level resistance to the injectable ephalosporins is now a serious problem.
In one clinical trial, dual treatment with single doses of IM gentamicin 240 mg plus oral azithromycin 2 g cured 100% of cases (lower one-sided 95% CI bound: 98.5%) and can be considered an alternative to ceftriaxone for persons with cephalosporin allergy (885).
They recommend dual therapy as the primary treatment regimen, although considering local resistance data is crucial. Dual therapy options include ceftriaxone in combination with azithromycin and cefixime in combination with azithromycin.
gonorrhoeae now has shown its ability to also develop high-level resistance to ceftriaxone,29,30 which is the last remaining option for empirical first-line treatment of gonorrhea; this STI pathogen, therefore, seems to be evolving into a true superbug and, in the near future, may become untreatable in certain
be ready to get more

Complete this form in 5 minutes or less

Get form